Loading...
XSWX
TECN
Market cap2.19bUSD
Apr 04, Last price  
148.40CHF
1D
-3.57%
1Q
-26.53%
Jan 2017
-6.61%
Name

Tecan Group AG

Chart & Performance

D1W1MN
No data to show
P/E
27.91
P/S
2.02
EPS
5.32
Div Yield, %
2.27%
Shrs. gr., 5y
1.55%
Rev. gr., 5y
7.97%
Revenues
934m
-13.04%
344,900,000405,929,000414,400,000396,042,000391,910,000370,548,000376,970,000391,108,000388,292,000399,518,000440,295,000506,227,000548,559,000593,795,000636,819,000730,879,000946,623,0001,144,261,0001,074,386,000934,278,000
Net income
68m
-48.77%
13,954,00040,639,00052,379,00025,623,00049,340,00016,204,00047,559,00042,155,00045,671,00040,216,00057,147,00054,542,00066,547,00070,696,00073,169,000103,685,000121,659,000121,126,000132,075,00067,664,000
CFO
149m
-7.49%
13,453,00066,087,00058,623,00058,929,00066,150,00062,520,00045,116,0002,405,00027,909,00048,191,00099,128,000118,801,00099,428,00092,702,00097,971,000207,416,000165,838,000127,474,000160,572,000148,541,000
Dividend
May 17, 20240.36282 CHF/sh
Earnings
Apr 18, 2025

Profile

Tecan Group AG provides laboratory instruments and solutions for pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. It operates through Life Sciences Business and Partnering Business segments. The company offers liquid handling and automation, microplate readers and washers, consumables, NGS reagents, immunoassays and microbodies, and software; Tecan Laberwax, an automation solution; Resolvex, a smart sample preparation solution for use in genomics, synthetic biology, drug discovery, analytical chemistry, cell biology, protein science, applied markets, and ELISA solutions. It also develops and manufactures laboratory instrument manufacturers with essential components comprising precision pumps, valves, robotic arms, and developer software for life science research, diagnostics, and various other industries; Synergence, platform-based automation solution; and Freedom EVO and Fluent instruments. The company operates in Switzerland and Other European countries, North America, Asia, and internationally. Tecan Group AG was founded in 1980 and is headquartered in Männedorf, Switzerland.
URL
https://www.tecan.com/
IPO date
May 04, 2001
Employees
3,000
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
934,278
-13.04%
1,074,386
-6.11%
1,144,261
20.88%
Cost of revenue
865,398
945,563
1,014,137
Unusual Expense (Income)
NOPBT
68,880
128,823
130,124
NOPBT Margin
7.37%
11.99%
11.37%
Operating Taxes
10,613
1,730
21,359
Tax Rate
15.41%
1.34%
16.41%
NOPAT
58,267
127,093
108,765
Net income
67,664
-48.77%
132,075
9.04%
121,126
-0.44%
Dividends
(38,320)
(37,024)
(35,597)
Dividend yield
0.84%
0.67%
Proceeds from repurchase of equity
(27,576)
1,798
833
BB yield
-0.04%
-0.02%
Debt
Debt current
261,393
12,240
14,278
Long-term debt
131,374
370,158
293,405
Deferred revenue
24,065
26,467
11,149
Other long-term liabilities
34,376
52,518
72,205
Net debt
232,593
245,532
10,221
Cash flow
Cash from operating activities
148,541
160,572
127,474
CAPEX
(15,279)
(19,433)
(36,234)
Cash from investing activities
(48,607)
(84,235)
(88,219)
Cash from financing activities
(81,302)
(50,568)
(47,816)
FCF
64,822
98,157
58,086
Balance
Cash
406,008
366,423
293,237
Long term investments
(245,834)
(229,557)
4,225
Excess cash
113,460
83,147
240,249
Stockholders' equity
1,113,091
1,348,910
1,357,720
Invested Capital
1,701,657
1,660,842
1,465,331
ROIC
3.47%
8.13%
7.58%
ROCE
3.72%
7.20%
7.18%
EV
Common stock shares outstanding
12,821
12,788
Price
202.60
-41.00%
343.40
-16.73%
412.40
-25.76%
Market cap
4,402,652
-16.52%
5,273,901
-22.93%
EV
4,648,184
5,284,122
EBITDA
135,685
199,617
197,178
EV/EBITDA
23.29
26.80
Interest
3,177
1,333
1,315
Interest/NOPBT
4.61%
1.03%
1.01%